KELLY ANNE OBRIEN

Allopathic & Osteopathic Physicians|Family Medicine LEES SUMMIT, MO NPI 1265605331

General Payments — all program years on this page

$2,330.81

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 156
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $340.95 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $340.9521

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $672.2749
2019 $656.2347
2020 $132.719
2021 $73.144
2022 $189.0711
2023 $266.4415
2024 $340.9521

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096755387 Novo Nordisk Inc $15.04 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104720667 AstraZeneca Pharmaceuticals LP $16.01 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105144456 ABBVIE INC. $16.32 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105496843 AstraZeneca Pharmaceuticals LP $24.94 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114813724 Exact Sciences Corporation $20.23 07/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131039690 PFIZER INC. $16.72 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131045016 PFIZER INC. $16.72 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131049208 PFIZER INC. $16.72 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131134693 PFIZER INC. $15.00 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131398422 PFIZER INC. $23.39 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131408404 PFIZER INC. $14.16 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131422776 PFIZER INC. $9.45 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131424656 PFIZER INC. $2.40 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131488745 PFIZER INC. $3.85 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131955018 PFIZER INC. $15.64 09/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135096924 Lilly USA, LLC $20.70 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135114470 Lilly USA, LLC $16.84 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135114472 Lilly USA, LLC $14.86 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135114474 Lilly USA, LLC $24.83 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143288922 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.96 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153494427 Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.17 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.